Entry Detail



General Information

Database ID:exR0351738
RNA Name:hsa-miR-708-5p
RNA Type:miRNA
Chromosome:chr11
Starnd:-
Coordinate:
Start Site(bp):79402077End Site(bp):79402099
External Links:hsa-miR-708-5p



Disease Information

Disease Name:Hepatocellular Carcinoma
Disease Category:Cancers
MeSH ID:D006528
Type:Neoplasms/Digestive System Neoplasms
Alias:Carcinoma, Hepatocellular//Carcinomas, Hepatocellular//Hepatocellular Carcinomas//Liver Cell Carcinoma, Adult//Liver Cancer, Adult//Adult Liver Cancer//Adult Liver Cancers//Cancer, Adult Liver//Cancers, Adult Liver//Liver Cancers, Adult//Liver Cell Carcinoma//Carcinoma, Liver Cell//Carcinomas, Liver Cell//Cell Carcinoma, Liver//Cell Carcinomas, Liver//Liver Cell Carcinomas//Hepatocellular Carcinoma//Hepatoma//Hepatomas



Expression Detail

GEO ID:GSE85679
Description:Serum miRNA in liver disease
Experimental Design:Surgery treatment
Case Disease Type:Hepatocellular Carcinoma
Case Disease SubType:NA
Case Sample:Hepatocellular Carcinoma Post surgery 4
Control Sample:Pre surgery
Number of Case:98
Number of Control:98
Number of Samples:196





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
ANKRD52
chr12
56237807
56258384
-
TUB
chr11
8019244
8106112
+
ERG28
chr14
75649791
75660876
-
KIAA1522
chr1
32741830
32774970
+
RGMA
chr15
93035273
93089204
-
RARG
chr12
53210567
53232980
-
GPCPD1
chr20
5544439
5611006
-
ZBTB7B
chr1
155002630
155018522
+
GLYR1
chr16
4803203
4847288
-
SMARCD1
chr12
50085200
50100707
+
UBE2Z
chr17
48908407
48929056
+
SEH1L
chr18
12947133
12987536
+
LONRF2
chr2
100271875
100322501
-
ENSA
chr1
150600851
150629612
-
PTMS
chr12
6765516
6770952
+
ATXN2L
chr16
28823035
28837237
+
FAM102A
chr9
127940582
127980989
-
TOB2
chr22
41433494
41446801
-
SLC31A1
chr9
113221544
113264492
+
PTPN23
chr3
47381011
47413435
+
TEX261
chr2
70985942
70994873
-
E2F4
chr16
67192155
67198918
+
N4BP1
chr16
48538726
48620148
-
FOXK1
chr7
4682295
4771442
+
DYRK1A
chr21
37365573
37526358
+
E2F6
chr2
11444375
11466177
-
CPSF2
chr14
92121969
92172145
+
NAPA
chr19
47487637
47515091
-
MAPK1
chr22
21754500
21867680
-
SMYD1
chr2
88067825
88113384
+
miRNA targets:NA
circRNA targets:
circRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
hsa_circ_0000417
chr12
69644908
69656342
+
hsa_circ_0001146
chr20
34241449
34246936
-
hsa_circ_0001164
chr20
45891031
45923523
-
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC009065.4
chr16
2119207
2120248
+
AC016876.2
chr17
7581964
7584086
-
AC026362.1
chr12
122975320
122982907
+
AC118758.3
chr7
56809214
56848800
-
MALAT1
chr11
65497688
65506516
+
NEAT1
chr11
65422774
65445540
+
OIP5-AS1
chr15
41283990
41309737
+
XIST
chrX
73820649
73852723
-
Display:



Experiment Detail

GEO ID:GSE85679
Sample Source:Blood
Source Fraction:Serum
Platform:GPL18941
Method:Microarray
Num of detected RNA Type:1
Num of detected RNAs of this Type:2524
Sample treatment protocol:NA
RNA Extract protocol:RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan).
RNA library preparation protocol:Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).



Reference

PMID:NA
Title:NA
Author:NA
Journal:NA
Description:NA